Dexcom officially breaks ground on Athenry site
DexCom, a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, has officially broken ground on its new state-of-the-art manufacturing facility, located in Athenry, County Galway. This marks the second step in the realisation of this facility, which will bring more than 1,000 jobs to the area and represents one of the biggest single private sector investments ever in the West of Ireland. The project is supported by the Irish Government through IDA Ireland.
The 1,000 available jobs include support in finance, HR, as well as a variety of engineering roles, ranging from leadership to graduate positions. Dexcom intends to build strong links with the local universities in Galway and nearby counties, particularly around engineering and quality assurance courses. In an additional boost to the local economy, it is expected that for every job created by Dexcom a further 1–1.7 jobs will be created indirectly*.
Dexcom is also further demonstrating its long-term commitment to the province announcing a 12-year naming-rights partnership with Connacht Rugby. ‘The Sportsground,’ which has been the home of Connacht Rugby since 1927, will now be known as ‘Dexcom Stadium.’
“The creation of the Dexcom manufacturing facility will undoubtedly be a game-changer for the West of Ireland,” said Barry Regan, Executive Vice President of Operations at Dexcom. “This is a pivotal moment for Dexcom and we are confident it will have an immensely positive impact in Galway and the wider region too, not only in relation to job creation but also as we become part of and contribute to this community. We’re already proud to be partnering with Connacht Rugby, and this is only the beginning.”
Michael Lohan, CEO of IDA Ireland, said: “The sod turning event is an important moment in this facility – first announced last year – becoming a reality. This important strategic investment by Dexcom, which is the first of its kind outside of the US, will have far reaching economic and social benefits for Athenry, the West and indeed all of Ireland. I wish continued success to Dexcom and assure the team of IDA Ireland’s continued support.”
Dexcom’s first manufacturing facility in Europe will ensure the flow of products throughout EMEA, with the potential to lower the cost of goods and improve sustainability by decreasing delivery time in transit. The new facility will have the capacity to produce millions of Dexcom rtCGM sensors each year, helping to improve the lives of people with diabetes in EMEA.
“This facility is strategically located in Europe, for Europe,” said Alex Moussa, SVP & General Manager EMEA at Dexcom. “This development demonstrates our commitment to sustainable growth and operational excellence in EMEA, as well as to the people we serve. This is the only beginning; we’re truly excited for what’s to come.”
For information about Dexcom job openings in Athenry go to: careers.dexcom.com/careers.
* Statistic provided by IDA Ireland
